Hospital News and Research

RSS

Health Care REIT signs definitive agreement to acquire Genesis for $2.4 billion

Health Care REIT, Inc. announced that it has signed a definitive agreement to acquire substantially all of the real estate assets of privately-owned Genesis HealthCare, a leading provider of short-term post-acute, rehabilitation, assisted living and long-term care services, for a purchase price of $2.4 billion.

28 Feb 2011

Omni Bio to expand Type 1 diabetes Phase I/II trial from 15 to 50 patients

Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.

28 Feb 2011

OrbusNeich's Sapphire II coronary dilatation catheter is now available in the market

OrbusNeich today announced that the next-generation Sapphire II coronary dilatation catheter is now commercially available, following CE Mark approval.

28 Feb 2011

Treat discomfort not fever say the new pediatric guidelines

According to a new report from the American Academy of Pediatrics (AAP), fevers alone are not a cause for intervention in children. Dr. Janice Sullivan, the lead author of the report says, “The focus should be on comfort and not on absolute temperature.” That’s because fever can be help fight illness, by slowing down the reproduction of bacteria and viruses or stimulating the body’s immune response she explains. “That’s a benefit of fever…and may shorten the time that your child remains ill,” she adds.

28 Feb 2011

TCD announces first patient treated in its TCD-717 Phase I trial

Traslational Cancer Drugs Pharma, S.L. (“TCD”) announced today that the first patient was treated on Friday the 18th of February with TCD-717 in a Phase I study performed in patients with advanced solid tumors. TCD-717 is a first-in-class, small molecule that precisely inhibits Choline Kinase Alpha, an enzyme heavily involved in the carcinogenic process. A total of 30 patients are planned to be treated in the trial, which will be conducted in accordance with FDA approval, in two leading medical centers in the U.S. The Principal Investigators are Dr. Julie Brahmer at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital in Baltimore; and Dr. Patricia LoRusso at the Barbara Ann Karmanos Cancer Institute in Detroit.

28 Feb 2011

Katie Couric to launch new citywide campaign for colon cancer screenings

In honor of National Colon Cancer Awareness Month, Katie Couric, the New York City Department of Health and Mental Hygiene, WCBS-TV and The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian Hospital will launch the "Make That Call" for colon cancer screening campaign.

28 Feb 2011

UCH installs GE's CARESCAPE Monitor B850 to enhance clinical decision making in the NICU

GE Healthcare today announced that the University of Colorado Hospital (UCH) has installed the new CARESCAPE™ Monitor B850, the company's latest advance in bedside patient monitoring, to help enhance clinical decision making in the Neonatal Intensive Care Unit (NICU). Deployed in UCH's 50-bed NICU and Neonatal OR, the CARESCAPE Monitor B850 enables access to critical patient information from any bedside monitor anywhere in the unit.

28 Feb 2011

State News: N.Y. Medicaid's compromise; Va. ups health spending; Medi-Cal ruling

One of the most familiar criticisms of the new national health care law is that it doesn't do much to contain costs. ... Cost controls are supposed to come later. "Later" has arrived now for Massachusetts' statewide plan, enacted in 2006 and similar in many ways to the federal one. Some 98 percent of all adults and nearly 100 percent of all children are covered, but costs have spiraled out of control.

28 Feb 2011

Positive results from Trius torezolid Phase 1 lung study

Trius Therapeutics, Inc. today announced results from its Phase 1 clinical trial to evaluate the ability of torezolid to penetrate into the lung for potential use to treat lung infections. In this study a 200 mg dose of torezolid phosphate was administered orally once-daily for three days to healthy adult volunteers. The trial achieved its primary goal of establishing the steady-state plasma pharmacokinetics and distribution of active drug into epithelial lining fluid (ELF).

28 Feb 2011

EPA approves BioNeutral's Ygiene 206 antimicrobial disinfectant

BioNeutral Group, Inc., a specialty life science technology-based company, today announced that it has received approval and registration from the Environmental Protection Agency (EPA) in response to the Company's regulatory application for its Ygiene™ 206.

28 Feb 2011

OTI receives additional order for 100,000 MediSmart healthcare biometric ID cards in Kenya

On Track Innovations Ltd., a global leader in contactless smart card solutions, has received an additional order for 100,000 MediSmartTM healthcare biometric ID cards for use by Kenyan-based Smart Applications International Ltd., a provider of technology driven secure healthcare solutions.

28 Feb 2011

PNH patients urge government to provide access to life-saving treatment

With so few people affected by rare diseases, how does a group of less than 90 patients across Canada make their voices heardon a life-and-death issue such as access to treatment? Barry Katsof, President of the Canadian Association of PNH Patients, says his group is turning to social media to ask others to take a stand with them in the fight for their lives.

28 Feb 2011

Western Medical installs Toshiba's vascular X-ray system to provide efficiency during diagnostic procedures

To increase diagnostic capabilities and provide patients with the highest quality care, Western Medical Center Santa Ana has installed Toshiba America Medical Systems, Inc.'s Infinix VF-i bi-plane vascular X-ray system with Volume Navigation 3D roadmapping.

28 Feb 2011

Ventas to acquire NHP shares for $7.4 billion

Ventas, Inc. and Nationwide Health Properties, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Ventas will acquire all of the outstanding shares of NHP in a stock-for-stock transaction valued at $7.4 billion, creating one of the largest publicly traded REITs and the leading healthcare REIT by equity value.

28 Feb 2011

p53 gene blocks EMT essential to cancer metastasis

Like a bounty hunter returning escapees to custody, a cancer-fighting gene converts organ cells that change into highly mobile stem cells back to their original, stationary state, researchers report online at Nature Cell Biology.

28 Feb 2011

MEPs, OETC visit new TB vaccine trial site to express support for candidate development

Emergent BioSolutions Inc. announced that a joint delegation of Members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium today visited the trial site where MVA85A, the world's most clinically advanced tuberculosis vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial.

28 Feb 2011

Researchers to examine thrombolysis for treatment of DVT in leg

Blood clots in the leg occur commonly. In one-half of the cases, the blood clot will break loose and travel through the bloodstream to the lungs - which may be life-threatening.

28 Feb 2011

New horse stem cell discovery aids in preclinical model development for human degenerative diseases

In a world first, pluripotent stem cells have been generated from horses by a team of researchers led by Dr. Andras Nagy at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital and Dr. Lawrence Smith at the University of Montreal's Faculty of Veterinary Science.

28 Feb 2011

Survey: 65% of patients in hospitals experience pain prevalence

Nearly two-thirds of the hospital in-patients who took part in a survey had experienced pain in the last 24 hours and 42% of those rated their pain as more than seven out of ten, where ten was the worst pain imaginable, according to the March issue of the Journal of Clinical Nursing.

28 Feb 2011

New national campaign to help reduce risk of pressure ulcers in hospital and post-acute care settings

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care settings.

28 Feb 2011

Hospital News and Research

Health Care REIT signs definitive agreement to acquire Genesis for $2.4 billion

Omni Bio to expand Type 1 diabetes Phase I/II trial from 15 to 50 patients

OrbusNeich's Sapphire II coronary dilatation catheter is now available in the market

Treat discomfort not fever say the new pediatric guidelines

TCD announces first patient treated in its TCD-717 Phase I trial

Katie Couric to launch new citywide campaign for colon cancer screenings

UCH installs GE's CARESCAPE Monitor B850 to enhance clinical decision making in the NICU

State News: N.Y. Medicaid's compromise; Va. ups health spending; Medi-Cal ruling

Positive results from Trius torezolid Phase 1 lung study

EPA approves BioNeutral's Ygiene 206 antimicrobial disinfectant

OTI receives additional order for 100,000 MediSmart healthcare biometric ID cards in Kenya

PNH patients urge government to provide access to life-saving treatment

Western Medical installs Toshiba's vascular X-ray system to provide efficiency during diagnostic procedures

Ventas to acquire NHP shares for $7.4 billion

p53 gene blocks EMT essential to cancer metastasis

MEPs, OETC visit new TB vaccine trial site to express support for candidate development

Researchers to examine thrombolysis for treatment of DVT in leg

New horse stem cell discovery aids in preclinical model development for human degenerative diseases

Survey: 65% of patients in hospitals experience pain prevalence

New national campaign to help reduce risk of pressure ulcers in hospital and post-acute care settings

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News